VERA Live signaler | Maksimer profitt med Getagraph.com

SELG 4863 min ago

@ $39.35

Utstedt: 24 apr 2024 @ 19:31

Avkastning: 0.76%

Forrige signal: apr 23 - 20:31

Forrige signal: Kjøp

Avkastning: -1.87 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States...

Stats
Dagens volum	822 396
Gjennomsnittsvolum	1.18M
Markedsverdi	2.18B
EPS	$0 ( 2024-03-26 )
Neste inntjeningsdato	( $-0.530 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-17.62
ATR14	$2.53 (6.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Young Joseph R	Sell	5 714	Class A Common Stock
2024-04-03	Grant Sean	Buy	99 828	Class A Common Stock
2024-04-03	Grant Sean	Sell	69 831	Class A Common Stock
2024-04-03	Grant Sean	Sell	10 988	Class A Common Stock
2024-04-03	Grant Sean	Sell	99 828	Stock Option (right to buy)

INSIDER POWER
32.71
Last 98 transactions
Buy: 7 469 518 \| Sell: 2 159 720

Volum Korrelasjon

Lang: 0.19 (neutral)

Kort: -0.89 (strong negative)

Signal:(69) Neutral

Vera Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner
LCAP	0.928
VTIP	0.912
CYTO	0.907
PAIC	0.896
MTEX	0.892
GAINL	0.889
RMRM	0.886
PROC	0.886
WNW	0.884
OP	0.873

10 Mest negative korrelasjoner
SCR	-0.952
BOCH	-0.924
NETE	-0.919
KIN	-0.914
SHSP	-0.904
IPHA	-0.899
DGLY	-0.898
SRRA	-0.898
THCPU	-0.898
ICON	-0.895

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Vera Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.07
( neutral )

-0.06
( neutral )

0.00
( neutral )

-0.14
( neutral )

-0.36
( neutral )

0.10
( neutral )

Vera Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$1.86M (0.00 %)
EPS:	$-2.25

FY	2023
Omsetning:	$0
Bruttogevinst:	$1.86M (0.00 %)
EPS:	$-2.25

FY	2022
Omsetning:	$0
Bruttogevinst:	$846 000 (0.00 %)
EPS:	$-3.35

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-8.00

Financial Reports:

No articles found.

Vera Therapeutics, Inc.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.